CASI Pharmaceuticals
CASI
CASI was delisted on the 25th of February, 2026.
27 hedge funds and large institutions have $5.8M invested in CASI Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
4% more funds holding
Funds holding: 26 → 27 (+1)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
18% less capital inflows, than outflows
Capital inflows: $67.4K | Capital outflows: $82.6K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
City National Bank
Beverly Hills,
Delaware
|
+$33K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$12.1K |
| 4 |
BlackRock Fund Advisors
San Francisco,
California
|
+$4.1K |
| 5 |
UBS
Zurich,
Switzerland
|
+$3.84K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Williams Jones & Associates
New York
|
-$43K |
| 2 |
Tower Research Capital (TRC)
New York
|
-$27K |
| 3 |
EEG
E.E. Geduld
|
-$9.5K |
| 4 |
BlackRock Institutional Trust
San Francisco,
California
|
-$1.48K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.29K |
CASI Hedge Fund Activity: Q3 2013 in Review
27 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in CASI Pharmaceuticals (CASI) for Q3 2013, worth a combined $5.8M — down 13% from $6.64M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CASI positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 7 trimmed.
The largest buyer was City National Bank, opening a new position worth an estimated $33K. The largest seller was Williams Jones & Associates, exiting entirely with an estimated $43K sold.
- 27 institutional investors held CASI Pharmaceuticals (CASI) as of Q3 2013, up from 26 in Q2 2013.
- Funds reported $5.8M of CASI Pharmaceuticals stock for Q3 2013, down 13% quarter-over-quarter.
- 3 funds opened new CASI Pharmaceuticals positions in Q3 2013 and 1 closed out, a net change of +2 holders.
- The largest CASI Pharmaceuticals buyer in Q3 2013 was City National Bank, an estimated $33K added.
- The largest CASI Pharmaceuticals seller in Q3 2013 was Williams Jones & Associates, an estimated $43K sold.
Based on aggregated 13F filings for Q3 2013.